stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Free cash flow
Pulse Biosciences, Inc's free cash flow for fiscal 2025 was −$54.5M, compared with −$36.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$216.1M. Over the past ten years it has ranged from −$54.5M (fiscal 2021) to −$3.4M (fiscal 2015); the current reading is higher than 18% of that period. Pulse Biosciences, Inc ranks 50th of 51 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$54.5M | — |
| FY2024 | −$36.5M | — |
| FY2023 | −$33.2M | — |
| FY2022 | −$47.4M | — |
| FY2021 | −$54.5M | — |
| FY2020 | −$35.8M | — |
| FY2019 | −$34.8M | — |
| FY2018 | −$24.2M | — |
| FY2017 | −$13.6M | — |
| FY2016 | −$8.1M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | −$167.8M | — |
| Jun 2026 | −$18.8M | — |
| Mar 2026 | −$14.6M | — |
| Dec 2025 | −$14.9M | — |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| ICUI ICU Medical, Inc. compare | $272.2M |
| NVST Envista Holdings Corporation compare | $244.6M |
| MMSI Merit Medical Systems, Inc. compare | $225.8M |
| TFX Teleflex Incorporated compare | $53.1M |
| ATRC AtriCure, Inc. compare | $52.9M |
| WRBY Warby Parker Inc. compare | $21.3M |
| STVN Stevanato Group S.p.A. compare | −$8.8M |
| PLSE Pulse Biosciences, Inc | −$216.1M |
| MMED MiniMed Group, Inc. compare | −$452.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement